Product
Seasonal influenza vaccine
3 clinical trials
6 indications
Indication
Multiple SclerosisIndication
Relapsing-RemittingIndication
BRCA1 MutationIndication
BRCA2 mutationIndication
InfluenzaIndication
HumanClinical trial
A Phase 3b, Multicenter, Open-label Study to Evaluate the Immune Response to, and the Safety of, Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Oral Ozanimod Compared to Non-pegylated Interferon (IFN)-β or No Disease Modifying TherapyStatus: Completed, Estimated PCD: 2023-11-15
Clinical trial
Influenza Vaccine Study in BRCA1 or BRCA2 CarriersStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy AdultsStatus: Recruiting, Estimated PCD: 2027-04-01